TARDBP and amyotrophic lateral sclerosis: A similar AAV-based approach has also been explored for amyotrophic lateral sclerosis (ALS), a condition characterized by motor neuron death caused by nuclear depletion and cytoplasmic aggregation of the splice factor TDP-43.